Everolimus Eluting Coronary Stent System
- UID
- MFG/MD/2019/000057_c87d460d00d3564b32bb8aea8cee3662_f4321c0d679f5ec7c949f7f9165e9612
- Device class
- Class D
- Brand name
- TM under process
- License holder
- KAMAL ENCON INDUSTRIES LIMITED
- Approving authority
- Sub Zonal Baddi
- Product information
- Everolimus Eluting Coronary Stent system is intended for use in the patient eligible for Percutaneous Transluminal Coronary Angioplasty (TM under process). Everolimus Eluting Coronary Stent System is indicated for improving coronary luminal diameter in patients with symptomatic ischemic disease due to discrete de novo lesions of length ≤ 48 mm in native coronary arteries with a reference vessel diameter of 2.00 to 4.50 mm
Everolimus Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2019/000057_c87d460d00d3564b32bb8aea8cee3662_f4321c0d679f5ec7c949f7f9165e9612. This device is marketed under the brand name TM under process. The license holder is KAMAL ENCON INDUSTRIES LIMITED, and it is classified as Device Class Class D. The approving authority is Sub Zonal Baddi.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.